Do you want to buy antibiotics online without prescription? http://buyantibiotics24h.com/ - This is pharmacy online for you!
Engelbrektson AL, Korzenik JR, Pittler A, Sanders ME, Klaenhammer TR, Leyer G and CL Kitts. 2009. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol 58: 663-670. Engelbrektson, A.L., Korzenik, J.R., Sanders, M.E., Clement, B.G., Leyer, G., Klaenhammer, T.R., & Kitts, C.L., (2006). Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Immunology and Medical Microbiology, 57, 239-250. Engelbrektson AL. 2005. Analysis of treatment effects on the microbial ecology of the gastrointestinal tract. PhD Thesis, California Polytechnic State University, San Luis Obispo, USA. Varcoe J, C Zook, J.Sui, S Leighton, F Busta and L Brady. 2002. Variable response to exogenous Lactobacillus acidophilus
NCFM® consumed in different delivery vehicles. J Appl Microbiol 93:900-906. Sui J, S Leighton, F Busta and L Brady. 2002. 16S ribosomal DNA analysis of the faecal lactobacilli composition of human subjects consuming a probiotic strain Lactobacillus acidophilus
NCFM®. J Appl Microbiol 93:907-912. Crowell DC. 1998. Microbial analysis of human intestinal flora after feeding Lactobacillus acidophilus
. M.S. Thesis, North Carolina State Univ., Raleigh. Gilliland SW, ML Speck, CF Nauyok, Jr and FG Giesbrecht. 1978. Influence of consuming nonfermented milk containing Lactobacillus acidophilus
on fecal flora of healthy males. J Dairy Sci 61:1-10. Gilliland SE, Speck ML, Morgan CG. Detection of Lactobacillus acidophilus
in feces of humans, pigs, and chickens. Appl Microbiol 1975; 30(4):541-545. Dunn SR, ML Simenhoff, KE Ahmed, WJ Gaughan, BO Eltayeb, M-ED Fitzpatrick, SM Emery, JW Ayres and KE Holt. 1998. Effect of oral administration of freeze-dried Lactobacillus acidophilus
on small bowel bacterial overgrowth in patients with end stage kidney disease: reducing uremic toxins and improving nutrition. Int. Dairy J. 8:545-553. Simenhoff ML, SR Dunn, GP Zollner, MED Fitzpatrick, SM Emery, WE Sandine and JW Ayres. 1996. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus
. Mineral and Electrolyte Metab 22:92-96. Strain LBA = NCFM®. Simenhoff ML and SR Dunn. 1996. Altered gut flora in uremia. J Renal Nutr 6:68-74. Ouwehand AC, Tiihonen K, Saarinen M, Putaala H and N Rautonen. 2009. Influence of a combination of Lactobacillus acidophilus
NCFM® and lactitol on healthy elderly: intestinal and immune parameters. British Journal of Nutrition, not known, 1-10. Schrezenmeir J, et al. 2004. Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections. Clin Ped 43: 239-249. Fisberg M, et al. 2002. Effect of oral nutritional supplementation with or without synbiotics and sickness and catch-up growth in preschool children. Int Pediatr 17(4): 215-222. Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Wolf BW, Chow J, et al. Fructooligosaccharides and Lactobacillus acidophilus
modify bowel function and protein catabolites excreted by healthy humans. J Nutr 2002; 132(10):3042-3050. Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian M-A, Simoneau G, Bergmann JF, Brassart D, Bornet F and AC Ouwehand. 2008. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol. Med Microbiol 53(1):107-13. Goldin BR and SL Gorbach. 1984. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Amer J Clin Nutr 39:756-761. Goldin BR and SL Gorbach. 1984. The effect of oral administration of Lactobacillus and antibiotics on intestinal bacterial activity and chemical induction of large bowel tumors. Dev Indus Microbiol 25:139-150. Goldin BR, L Swenson, J Dwyer, M Sexton and S Gorbach. 1980. Effect of diet and Lactobacillus acidophilus
supplements on human fecal bacterial enzymes. J Natl Cancer Instit 64:255-261. Thompson LU, DJA Jenkins, MAV Amer, R Reichert, A Jenking and J Kamulsky. 1982. The effect of fermented and
unfermented milks on serum cholesterol. Amer J Clin Nutr. 36:1106-1111. Montes RG, TM Bayless, JM Saavedra and JA Perman. 1995. Effect of milks inoculated with Lactobacillus acidophilus
or a yogurt starter culture in lactosemaldigesting children. J Dairy Sci 78:1657-1664. Lin M-Y, D Savaiano and S Harlander. 1991. Influence of nonfermented dairy products containing bacterial starter cultures on lactose maldigestion in humans. J Dairy Sci 74:87-95. McDonough FE, AD Hitchins, NP Wong, P Wells and CE Bodwell. 1987. Modification of sweet acidophilus milk to improve utilization by lactose-intolerant persons. Am J Clin Nutr 45:570-574. Savaiano DA, DAG Abou El Anouar, DE Smith and MD Levitt. 1984. Lactose malabsorption from yogurt, pasteurized yogurt, sweet acidophilus milk, and cultured milk in lactase-deficient individuals. Amer J Clin Nutr 40:1219-1223. Newcomer AD, HS Park, PC O’Brien and DB McGill. 1983. Response of patients with irritable bowel syndrome and lactase deficiency using unfermented acidophilus milk. Amer J Clin Nutr 38:257-263. Kim GS and SE Gilliland. 1983. Lactobacillus acidophilus
as a dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci 66:959-966. Payne DL, JD Welsh, CV Manion, A Tsegaye, A and LD Herd. 1981. Effectiveness of milk products in dietary management of lactose malabsorption. Amer J Clin Nutr 34:2711-2715. Leyer, G.J., Li, S., Mubasher, M.E., Reifer, C., Ouwehand, A.C. 2009. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124: e172-e179. [Abstract] Ringel Y, Palsson OS, Leyer G, Causey S, Yeskel SE, Faber SM and Ringel-Kulka T. 2008. Probiotic bacteria Lactobacillus acidophilus
NCFM® and Bifidobacterium lactis
Bi-07 improve symptoms of bloating patients with functional bowel disorders (FBD). Gastroenterology 134(4 Suppl. 1): A549. [Abstract] Guerrero M, M Dohnalek, P Newton, J Calva, F Tuz, F Arteaga, T Costigan, M Hilty and G Ruiz-Palacios. 1996. Feeding of a probiotic for prevention of diarrhea in young children. Abstracts of the 1st World Congress of Pediatric Infectious Diseases, 15th InterAmerican Congress of Pediatric Infectious Diseases, Abstract # C041. Ruiz-Palacios G, ML Guerrero, M Hilty, M Dohnalek, P Newton, JJ Calva, T Costigan, F Tuz and F Arteaga. 1996. Feeding of a probiotic for the prevention of community-acquired diarrhea in young Mexican children. Pediatric Research 39 (Part 2):104, Abstract #1089. [Abstract] Ruiz-Palacios G, F Tuz, F Arteaga, ML Guerrero, M Dohnalek and M Hilty. 1996. Tolerance and fecal colonization with Lactobacillus reuteri in children fed a beverage with a mixture of Lactobacillus ssp. Pediatric Research 39 (Part 2):104, Abstract #1090. [Abstract] Guerrero M, M Dohnalek, P Newton, O Kuznetsova, T Murphy, J Calva, M Hilty, T Costigan and G Ruiz- Palacios. 1996. Effect of probiotic-containing beverages on incidence of diarrhea. Abstracts of the 1st World Congress of Pediatric Infectious Diseases, 15th InterAmerican Congress of Pediatric Infectious Diseases, Abstract # 610:45-2. Heiser CR, Ernst JA, Barrett JT, French N, Schutz M and MP Dube. 2004. Probiotics, soluble fiber, and L-Glutamine (GLN) reduce nelfinavir (NFV) – or lopinavir/ritonavir (LPV/r)-related diarrhea. J. Int. Assoc. Physicians AIDS Care (Chic Ill ). 3(4):121-129. Faber S, Rigden S, Lukaczer D. The use of probiotics in the treatment of irritable bowel syndrome: two case reports. Altern Ther Health Med 2005; 11(4):60-62. Faber SM. 2003. Are probiotics usefull in irritable bowel syndrome? J Clin Gastroenterol 37:93-94. [Abstract] Faber SM. 2003. Comparison of probiotics with antibiotics to probiotics alone in treatment of diarrhea predominant IBS (D-IBS), alternating (A-IBS) and constipation (C-IBS) patients. Gastroenterology 124(4): A687- A688. [Abstract] Faber SM. 2000. Treatment of abnormal gut flora improves symptoms in patients with irritable bowel syndrome. Am J Gastroenterol. 95(9):2533.
Ouwehand AC, Lahtinen SJ. 2009. Lactobacillus acidophilus
NCFM®. In: Handbook of probiotics and prebiotics. Wiley & Sons, New Jersey. Edited by Lee Y-K, Salminen SJ. 2nd edition. pp. 417-419. Philipp S, Ouwehand AC. Overview of prophylactic studies on probiotics. Reduction of incidence and duration of disease. NutraFoods 2008; 7(2/3):45-50. Donaldson MS. 2004. Nutrition and Cancer: A review of the evidence for an anti-cancer diet. Nutr J 3(19):1-21. Brassart D. 2003. Lactobacillus acidophilus NCFM®: Functional properties of a unique probiotic strain. IDF Seminar on Aroma and Texture of Fermented Milk, Kolding, Denmark (06/2002). International Dairy Federation special issue. n° 1: 36-143. Klaenhammer T, E Altermann, F Arigoni, A Bolotin, F Breidt, J Broadbent, R Cano, S Chaillou, J Deutscher, M Gasson, M van de Guchte, J Guzzo, A Hartke, T Hawkins, P Hols, R Hutkins, M Kleerebezem, J Kok, O Kuipers, M Lubbers, E Maguin, L McKay, D Mills, A Nauta, R Overbeek, H Pel, D Pridmore, M Saier, D van Sinderen, A Sorokin, Steele, D O’Sullivan, W de Vos, B Weimer, M Zagorec and R Siezen. 2002. Discovering lactic acid bacteria by genomics. Antonie van Leeuwenhoek 82: 59-71. Sanders ME and TR Klaenhammer. 2001. The scientific basis of Lactobacillus acidophilus
NCFM® functionality as a probiotic. J Dairy Sci. 84:319-331. Reid G. 1999. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 65:3763-3766. Klaenhammer TR, MJ Kullen. 1999. Selection and design of probiotics. Intl J Food Micro 50:45-57. Schauss AG. 1990. Lactobacillus acidophilus: method of action, clinical application, and toxicity data. J Adv Med 3:163-178. Klaenhammer TR. 1982. Microbiological considerations in the selection and preparation of Lactobacillus strains for use as dietary adjuncts. J Dairy Sci 65:1339-1349. Sanders ME, DC Walker, KM Walker, K Aoyama and TR Klaenhammer. 1996. Performance of commercial cultures in fluid milk applications. J Dairy Sci 79:943-955. (Strain LH1 = NCFM®). Iturriria-Laverty K, PS Tong and ME Sanders. 1999. Microbiological stability of probiotic and starter bacteria in commercial yogurt and cottage cheese. J Dairy Sci 82 (Suppl. 1):6. Abstract D23. Ding WK, Shah NP. 2007. Acid, bile, and heat tolerance of free and microencapsulated probiotic bacteria. J Food Sci 2007; 72(9):M446-M450. Ding WK, Shah NP. 2009. Effect of various encapsulating materials on the stability of probiotic bacteria. J Food Sc 73(7): M360-M367. Ding WK, Shah NP. 2009 An Improved Method of Microencapsulation of Probiotic Bacteria for Their Stability in Acidic and Bile Conditions during Storage. J Food Sci.R Sreekumar, Z Al-Attabi, HC Deeth and MS Turner. 2009. Volatile sulfur compounds produced by probiotic bacteria in the presence of cysteine or methionine. Lett Appl Microbiol 48:777-782. Azcarate-Peril MA, Tallon R, Klaenhammer TR. 2009. Temporal gene expression and probiotic attributes of Lactobacillus acidophilus
during growth in milk. J Dairy Sci 92:870-886. M Liu, A Nauta, C Francke and RJ Siezen. 2008. Comparative Genomics of Enzymes in Flavor-Forming Pathways from Amino Acids in Lactic Acid Bacteria. Appl Environ Microbiol 74:4590-4600. CE Trahan. 2008. Lactobacillus acidophilus
NCFM® Survival in Acidified Yogurts. MSc thesis, North-Carolina State University.
(IFRAME) Acetaminophen (Tylenol) Poisoning Alert for Dogs and Cats3580 Nafziger Road, Wellesley, ON, N0B 2T0Phone: 519-656-2200Fax: 519-656-2300Email: email@example.comWebsite: www.wellesleyvet.comAcetaminophen (Tylenol) Poisoning Alert for Dogs and Cats"IMPORTANT: Acetaminophen (Tylenol) is very dangerous to dogs and cats."Acetaminophen (Tylenol®, Paracetamol, APAP, N-acetyl-
Article 223: Asava Massage - part 8 For years, medical science felt they were finally winning the battle against the tiny disease-causing microbes which had ravaged mankind for centuries, …as a result, they announced control of many diseases, yet many of these “controlled” diseases, such as polio, dengue and yellow fever, and smallpox are making a come back, tuberculosis has grown resist